---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-055019"
form_type: "8-K"
ticker: null
cik: "0000727207"
company_name: "Accelerate Diagnostics, Inc"
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T05:01:29.223753+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Accelerate Diagnostics receives Nasdaq delisting notice for bid price below $1.00

## Summary
- On April 26, 2024, Nasdaq notified Accelerate Diagnostics that its bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until Oct 23, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by Oct 23, company may be eligible for additional 180-day extension if it meets other listing standards.
- Company considering options including a reverse stock split; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001104659-24-055019
- form_type: 8-K
- cik: 0000727207
- company_name: Accelerate Diagnostics, Inc
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727207/000110465924055019/0001104659-24-055019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727207/000110465924055019/tm2412911d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-055019
- JSON: https://secwatch.observer/filing/0001104659-24-055019.json
- Plain text: https://secwatch.observer/filing/0001104659-24-055019.txt

## Key facts
- Listing & Compliance Notices
  Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 26, 2024, Accelerate Diagnostics, Inc. (the “Company”) received written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or unti
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465924055019/0001104659-24-055019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.